• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理清患者和公众在医疗决策中的参与:为何差异至关重要。

Disentangling patient and public involvement in healthcare decisions: why the difference matters.

作者信息

Fredriksson Mio, Tritter Jonathan Q

机构信息

Department of Public Health and Caring Sciences, Uppsala University, Sweden.

School of Languages and Social Sciences, Aston University, UK.

出版信息

Sociol Health Illn. 2017 Jan;39(1):95-111. doi: 10.1111/1467-9566.12483. Epub 2016 Nov 11.

DOI:10.1111/1467-9566.12483
PMID:27862007
Abstract

Patient and public involvement has become an integral aspect of many developed health systems and is judged to be an essential driver for reform. However, little attention has been paid to the distinctions between patients and the public, and the views of patients are often seen to encompass those of the general public. Using an ideal-type approach, we analyse crucial distinctions between patient involvement and public involvement using examples from Sweden and England. We highlight that patients have sectional interests as health service users in contrast to citizens who engage as a public policy agent reflecting societal interests. Patients draw on experiential knowledge and focus on output legitimacy and performance accountability, aim at typical representativeness, and a direct responsiveness to individual needs and preferences. In contrast, the public contributes with collective perspectives generated from diversity, centres on input legitimacy achieved through statistical representativeness, democratic accountability and indirect responsiveness to general citizen preferences. Thus, using patients as proxies for the public fails to achieve intended goals and benefits of involvement. We conclude that understanding and measuring the impact of patient and public involvement can only develop with the application of a clearer comprehension of the differences.

摘要

患者及公众参与已成为许多发达卫生系统不可或缺的一部分,并被视为改革的关键驱动力。然而,人们很少关注患者与公众之间的差异,患者的观点往往被视为涵盖了普通公众的观点。我们运用理想类型法,以瑞典和英国的实例分析患者参与和公众参与之间的关键差异。我们强调,与作为反映社会利益的公共政策主体参与的公民不同,患者作为卫生服务使用者有局部利益。患者利用经验知识,关注产出合法性和绩效问责制,追求典型代表性,并直接回应个人需求和偏好。相比之下,公众贡献源于多样性的集体观点,以通过统计代表性、民主问责制和对普通公民偏好的间接回应实现的输入合法性为核心。因此,将患者用作公众的替代无法实现参与的预期目标和益处。我们得出结论,只有更清晰地理解这些差异,才能更好地理解和衡量患者及公众参与的影响。

相似文献

1
Disentangling patient and public involvement in healthcare decisions: why the difference matters.理清患者和公众在医疗决策中的参与:为何差异至关重要。
Sociol Health Illn. 2017 Jan;39(1):95-111. doi: 10.1111/1467-9566.12483. Epub 2016 Nov 11.
2
Blueprint for a deliberative public forum on biobanking policy: were theoretical principles achievable in practice?关于生物银行政策的审议性公共论坛蓝图:理论原则在实践中是否可行?
Health Expect. 2013 Jun;16(2):211-24. doi: 10.1111/j.1369-7625.2011.00701.x. Epub 2011 Jun 7.
3
Representativeness, legitimacy and power in public involvement in health-service management.公众参与卫生服务管理中的代表性、合法性与权力
Soc Sci Med. 2008 Dec;67(11):1757-65. doi: 10.1016/j.socscimed.2008.09.024. Epub 2008 Oct 14.
4
Which public and why deliberate?--A scoping review of public deliberation in public health and health policy research.哪些公众以及为何是刻意选择的?——对公共卫生与卫生政策研究中公众参与审议的范围界定审查
Soc Sci Med. 2015 Apr;131:114-21. doi: 10.1016/j.socscimed.2015.03.009. Epub 2015 Mar 6.
5
Who wants to be involved in health care decisions? Comparing preferences for individual and collective involvement in England and Sweden.谁希望参与医疗保健决策?比较英国和瑞典对个人参与和集体参与的偏好。
BMC Public Health. 2017 Jul 14;18(1):18. doi: 10.1186/s12889-017-4534-y.
6
Citizen science or scientific citizenship? Disentangling the uses of public engagement rhetoric in national research initiatives.公民科学还是科学公民身份?厘清国家研究计划中公众参与言辞的用途。
BMC Med Ethics. 2016 Jun 4;17(1):33. doi: 10.1186/s12910-016-0117-1.
7
Public involvement in the Swedish health system: citizen dialogues with unclear outcomes.公众参与瑞典卫生系统:公民对话,结果不明。
BMC Health Serv Res. 2023 Sep 4;23(1):947. doi: 10.1186/s12913-023-09947-x.
8
Reluctant rationers: public input to health care priorities.不情愿的分配者:公众对医疗保健优先事项的投入。
J Health Serv Res Policy. 1997 Apr;2(2):103-11. doi: 10.1177/135581969700200208.
9
'Ordinary people only': knowledge, representativeness, and the publics of public participation in healthcare.“仅面向普通人”:知识、代表性与公众参与医疗保健的群体
Sociol Health Illn. 2008 Jan;30(1):35-54. doi: 10.1111/j.1467-9566.2007.01027.x.
10
Citizen participation in health decision-making: past experience and future prospects.公民参与健康决策:过去的经验与未来的前景
J Public Health Policy. 2002;23(1):12-32.

引用本文的文献

1
Evaluating the impact of a patient-representative model of support for women affected by cervical cancer.评估患者代表模式对受宫颈癌影响女性的支持效果。
Womens Health (Lond). 2025 Jan-Dec;21:17455057251351415. doi: 10.1177/17455057251351415. Epub 2025 Jul 18.
2
Determining a role for Patient and Public Involvement and Engagement (PPIE) in genomic data governance for cancer care.确定患者及公众参与和介入(PPIE)在癌症护理基因组数据治理中的作用。
Eur J Hum Genet. 2025 May 23. doi: 10.1038/s41431-025-01866-1.
3
The impact of Covid-19 on inter-organizational coordination in Swedish eldercare: a mixed methods study.
新冠疫情对瑞典老年护理中组织间协调的影响:一项混合方法研究。
BMC Health Serv Res. 2025 Mar 21;25(1):416. doi: 10.1186/s12913-025-12576-1.
4
Legitimacy as Social Infrastructure: A Critical Interpretive Synthesis of the Literature on Legitimacy in Health and Technology.作为社会基础设施的合法性:对健康与技术领域合法性文献的批判性解释性综述
JMIR Hum Factors. 2025 Mar 5;12:e48955. doi: 10.2196/48955.
5
A mixed-methods model for healthcare system responsiveness to public health: insights from Iranian experts.医疗保健系统对公共卫生响应的混合方法模型:来自伊朗专家的见解。
Health Res Policy Syst. 2025 Feb 21;23(1):24. doi: 10.1186/s12961-025-01295-y.
6
Causes, Solutions and Health Inequalities: Comparing Perspectives of Professional Stakeholders and Community Participants Experiencing Low Income and Poor Health in London.原因、解决方案与健康不平等:比较伦敦低收入和健康状况不佳的专业利益相关者与社区参与者的观点
Health Expect. 2024 Dec;27(6):e70128. doi: 10.1111/hex.70128.
7
From polarity to plurality: Perceptions of COVID-19 and policy measures in England and Scotland.从两极到多元:英格兰和苏格兰对 COVID-19 及政策措施的看法。
Health Expect. 2024 Jun;27(3):e14069. doi: 10.1111/hex.14069.
8
Enabling primary healthcare service development with patient participation: a qualitative study of the internal facilitator role in Norway.促进初级保健服务发展的患者参与:挪威内部促进者角色的定性研究。
Prim Health Care Res Dev. 2023 Sep 27;24:e57. doi: 10.1017/S1463423623000488.
9
Evidence-Informed Deliberative Processes for UHC: Progress, Potential and Prudence Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".基于循证的全民医保决策过程:进展、潜力与审慎——评“基于循证的卫生福利包设计决策过程:第二部分:实用指南”
Int J Health Policy Manag. 2023;12:7541. doi: 10.34172/ijhpm.2022.7541. Epub 2023 Feb 13.
10
Barriers and Enablers to Evaluating Outcomes From Public Involvement in Health Service Design: An Interpretive Description.公众参与卫生服务设计的效果评估的障碍和促成因素:阐释性描述。
Qual Health Res. 2023 Sep;33(11):983-994. doi: 10.1177/10497323231191048. Epub 2023 Aug 7.